Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes (Q43461389)

23 November 2017

title

Non-proteinuric pathways in loss of renal function in patients with type 2 diabetes (English)

1 reference

23 November 2017

1 reference

2

Piero Ruggenenti

1 reference

23 November 2017

1

Esteban Porrini

2 references

ORCID Public Data File 2021

23 November 2017

9

Aiko P J de Vries

1 reference

23 November 2017

Carl Erik Mogensen

3

1 reference

23 November 2017

Drazenka Pongrac Barlovic

4

1 reference

23 November 2017

Manuel Praga

5

1 reference

23 November 2017

Josep M Cruzado

6

1 reference

23 November 2017

Radovan Hojs

7

1 reference

23 November 2017

Manuela Abbate

8

1 reference

23 November 2017

ERA-EDTA diabesity working group

10

1 reference

23 November 2017

publication date

1 May 2015

1 reference

The Lancet: Diabetes & Endocrinology

23 November 2017

published in

1 reference

23 November 2017

volume

3

1 reference

23 November 2017

issue

5

1 reference

23 November 2017

page(s)

382-391

1 reference

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Temporal trends in the prevalence of diabetic kidney disease in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Changes in diabetes-related complications in the United States, 1990-2010

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The June 2003 Barry M. Brenner Comgan lecture. The future of renoprotection: frustration and promises

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Effects of Manidipine and Delapril in Hypertensive Patients With Type 2 Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Clinical practice. Nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The stages in diabetic renal disease. With emphasis on the stage of incipient diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Nonalbuminuric renal insufficiency in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Glomerular Filtration Rate, Cardiorenal End Points, and All-Cause Mortality in Type 2 Diabetic Patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Clinical significance of nonalbuminuric renal impairment in type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Renal Dysfunction in the Presence of Normoalbuminuria in Type 2 Diabetes: Results from the DEMAND Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Normoalbuminuric diabetic kidney disease in the U.S. population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Non-albuminuric renal disease among subjects with advanced stages of chronic kidney failure related to type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Poor glycemic control in diabetes and the risk of incident chronic kidney disease even in the absence of albuminuria and retinopathy: Atherosclerosis Risk in Communities (ARIC) Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Risk factors for the development of albuminuria and renal impairment in type 2 diabetes--the Swedish National Diabetes Register (NDR).

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Glomerular hyperfiltration and renal disease progression in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The Effect of Age on Creatinine Clearance in Men: A Cross-sectional and Longitudinal Study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Monitoring kidney function in type 2 diabetic patients with incipient and overt diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Chronic proteinuric nephropathies: outcomes and response to treatment in a prospective cohort of 352 patients with different patterns of renal injury

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The GFR and GFR decline cannot be accurately estimated in type 2 diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Markers of and risk factors for the development and progression of diabetic kidney disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Epidemiology and risk factors for diabetic kidney disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Differences in decline in GFR with age between males and females. Reference data on clearances of inulin and PAH in potential kidney donors

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Gender differences in predictors of the decline of renal function in the general population

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Global transcription profiling of estrogen activity: estrogen receptor alpha regulates gene expression in the kidney

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Sexual dimorphism in the aging kidney: differences in the nitric oxide system

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Sugar, sex, and TGF-β in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Longevity in obese and lean male and female rats of the Zucker strain: prevention of hyperphagia

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Estrogen accelerates the development of renal disease in female obese Zucker rats

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Estrogen worsens incipient hypertriglyceridemic glomerular injury in the obese Zucker rat.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Clinical implication of metabolic syndrome on chronic kidney disease depends on gender and menopausal status: results from the Korean National Health and Nutrition Examination Survey.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Association between metabolic syndrome and chronic kidney disease in perimenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Postmenopausal hormone replacement improves proteinuria and impaired creatinine clearance in type 2 diabetes mellitus and hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Effects of short-term transdermal hormone replacement therapy on glycaemic control, lipid metabolism, C-reactive protein and proteinuria in postmenopausal women with type 2 diabetes or hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

HRT does not improve urinary albumin excretion in postmenopausal diabetic women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Oral contraceptive use and hormone replacement therapy are associated with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The relationship between albuminuria and hormone therapy in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Oral estrogen therapy in postmenopausal women is associated with loss of kidney function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Metabolic syndrome and the risk for chronic kidney disease among nondiabetic adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The metabolic syndrome and chronic kidney disease in U.S. adults

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Gender differences in the metabolic syndrome and their role for cardiovascular disease.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Sex differences in the relation of body composition to markers of inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Sex Differences in the Prediction of Type 2 Diabetes by Inflammatory Markers: Results from the MONICA/KORA Augsburg case-cohort study, 1984-2002

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Gender difference in the impact of type 2 diabetes on coronary heart disease risk

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European Type 2 (non-insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Rate and determinants of association between advanced retinopathy and chronic kidney disease in patients with type 2 diabetes: the Renal Insufficiency And Cardiovascular Events (RIACE) Italian multicenter study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Is nonalbuminuric renal insufficiency in type 2 diabetes related to an increase in intrarenal vascular disease?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Adverse renal consequences of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Glomerular hyperfiltration predicts the development of microalbuminuria in stage 1 hypertension: the HARVEST.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Effect of blood glucose control on increased glomerular filtration rate and kidney size in insulin-dependent diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Insulin resistance, hyperinsulinemia, and renal injury: mechanisms and implications

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Glomerular Filtration Rate and Renal Plasma Flow in Short-term and Long-term Juvenile Diabetes Mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Glomerular Filtration Rate and Renal Plasma Flow in Normal and Diabetic Man during Elevation of Blood Sugar Levels

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Renal hyperfiltration in type 2 diabetes: effect of age-related decline in glomerular filtration rate

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Preventing microalbuminuria in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Renal and retinal effects of enalapril and losartan in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Time to abandon microalbuminuria?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Measurable urinary albumin predicts cardiovascular risk among normoalbuminuric patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The need for early predictors of diabetic nephropathy risk: is albumin excretion rate sufficient?

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The kidney in diabetes: dynamic pathways of injury and repair. The Camillo Golgi Lecture 2007.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Pathologic classification of diabetic nephropathy.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Patterns of renal injury in NIDDM patients with microalbuminuria

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Non-proteinuric diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Tubulointerstitial disease in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Fatty kidney: emerging role of ectopic lipid in obesity-related renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

The emerging concept of chronic kidney disease without clinical proteinuria in diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

Sex differences in the development of kidney disease in individuals with type 1 diabetes mellitus: a contemporary analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2815%2900094-7

7 January 2021

10.1016/S2213-8587(15)00094-7

Identifiers

DOI

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k33ujq6ckzgjdbbwth6huenejy

30 July 2022

mapped directly with Wikidata item

Fatcat ID

release_k33ujq6ckzgjdbbwth6huenejy

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/k33ujq6ckzgjdbbwth6huenejy

30 July 2022

mapped directly with Wikidata item

https://api.fatcat.wiki/v0/release/k33ujq6ckzgjdbbwth6huenejy

1 reference

30 July 2022